Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • Scientists Finish the Human Genome at Last https://t.co/bTRwmNjHwP
    about 6 hours ago
  • While the public's attention for the past 18 months has been focused on Covid-19, the problem of opioid overdoses a… https://t.co/gr0q6FkShP
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Drug Overdose Epidemic Accelerating https://t.co/rZP0zmFVgK #Science #Business
    about 1 day ago
  • "Unvaccinated people aren’t a random group of defectors who are trying to be deviant." @edyong209 talks to Dr. Rhea… https://t.co/FkzZWK83OE
    about 1 day ago
  • U.S. drops cases against five researchers accused of hiding ties to Chinese military https://t.co/0D4YvwvjZq
    about 2 days ago

Please share Science & Enterprise

Tissue Culture: A Novel Propagation Method for Cannabis Industry

One of the more pressing concerns is the development of propagation methods that meet the requirements of mass production. . . . → Read More: Tissue Culture: A Novel Propagation Method for Cannabis Industry

Covid-19 Antibody Developer Raises $483M in IPO

Wall Street sign

A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO

Industry, Univ Labs Partner on Cannabinoid Pain Drug

Cannabis plant

A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis. . . . → Read More: Industry, Univ Labs Partner on Cannabinoid Pain Drug

Wheat Genome Study IDs Critical Genes, Traits

Curtis Pozniak in wheat field

An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

Stop signs graphic

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial

New Company IDs Drugs Targeting Cancer Cell Networks

Cancer magnified

A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks

Int’l Lab Network to Assess Covid-19 Vaccines

Syringes

Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols. . . . → Read More: Int’l Lab Network to Assess Covid-19 Vaccines

Group Advancing Electronic Spinal Cord Injury Therapies

Spine

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

Early Trial Results Show Antibody Treating Covid-19

SARS-Cov-2 virus

First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19

Covid-19 Vaccines, Therapies – 31 August 2020

Covid-19 vaccine and therapy tracker

The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium. . . . → Read More: Covid-19 Vaccines, Therapies – 31 August 2020